Novan, Inc (NOVN)

Etorro trading 970x250
Novan, Inc (NOVN) Logo

About Novan, Inc

Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete’s foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is headquartered in Morrisville, North Carolina. Address: 4105 Hopson Road, Morrisville, NC, United States, 27560

Novan, Inc News and around…

Latest news about Novan, Inc (NOVN) common stock and company :

Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference
14 Jan, 2022 Yahoo! Finance

DURHAM, N.C., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that data from the Company’s completed Phase 2 and Phase 3 clinical studies of berdazimer 10.3% gel (previously referred to as SB206) for molluscum contagiosum will be presented at the 2022 Winter Clinical Dermatology Conference, being held January 14-19, 2022, in Koloa, Hawaii. Berdazimer 10.3% gel, containing new chemical entity berdazimer (sodium), is in late-stage developmen

Advisors' Inner Circle Fund III Buys Petroleo Brasileiro SA Petrobras, Gazprom PJSC, Roche ...
28 Dec, 2021 Yahoo! Finance

Investment company Advisors' Inner Circle Fund III (Current Portfolio) buys Petroleo Brasileiro SA Petrobras, Gazprom PJSC, Roche Holding AG, Philip Morris International Inc, Royal Bank of Canada, sells TotalEnergies SE, Rio Tinto PLC, Itau Unibanco Holding SA, China Overseas Land & Investment, CLP Holdings during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Advisors' Inner Circle Fund III.

IWC's Holdings Imply 45% Gain Potential
27 Dec, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Micro-Cap ETF (IWC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $203.66 per unit.

Principal International Multi-Factor ETF Buys Dassault Systemes SE, Universal Music Group NV, ...
14 Dec, 2021 Yahoo! Finance

Investment company Principal International Multi-Factor ETF (Current Portfolio) buys Dassault Systemes SE, Universal Music Group NV, Lightspeed Commerce Inc, DNB Bank ASA, DNB Bank ASA, sells Nestle SA, Roche Holding AG, ASML Holding NV, Novartis AG, Novo Nordisk A/S during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Principal International Multi-Factor ETF.

DWS CROCI(R) International VIP Buys Roche Holding AG, Novartis AG, Tokyo Electron, Sells Novo ...
13 Dec, 2021 Yahoo! Finance

Investment company DWS CROCI(R) International VIP (Current Portfolio) buys Roche Holding AG, Novartis AG, Tokyo Electron, Sanofi SA, CRH PLC, sells Novo Nordisk A/S, UCB SA, Ono Pharmaceutical Co, Toyota Motor Corp, Shionogi during the 3-months ended 2021Q3, according to the most recent filings of the investment company, DWS CROCI(R) International VIP.

ON BlackRock Advantage International Equity Portfolio Buys L'Oreal SA, SAP SE, Novartis AG, ...
13 Dec, 2021 Yahoo! Finance

Investment company ON BlackRock Advantage International Equity Portfolio (Current Portfolio) buys L'Oreal SA, SAP SE, Novartis AG, Koninklijke Ahold Delhaize NV, Terumo Corp, sells Keyence Corp, Telefonaktiebolaget L M Ericsson, Commonwealth Bank of Australia, Aristocrat Leisure, Prosus NV during the 3-months ended 2021Q3, according to the most recent filings of the investment company, ON BlackRock Advantage International Equity Portfolio.

Tweedy, Browne Fund Inc. Buys Alibaba Group Holding, Baidu Inc, Tencent Holdings, Sells Alibaba ...
11 Dec, 2021 Yahoo! Finance

Investment company Tweedy, Browne Fund Inc. (Current Portfolio) buys Alibaba Group Holding, Baidu Inc, Tencent Holdings, FMC Corp, NORMA Group SE, sells Alibaba Group Holding, Baidu Inc, Alphabet Inc, Johnson & Johnson, Novartis AG during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Tweedy, Browne Fund Inc..

Tweedy, Browne International Value Fund II - Currency Unhedged Buys Alibaba Group Holding, ...
11 Dec, 2021 Yahoo! Finance

Investment company Tweedy, Browne International Value Fund II - Currency Unhedged (Current Portfolio) buys Alibaba Group Holding, Baidu Inc, Tencent Holdings, FMC Corp, NORMA Group SE, sells Alibaba Group Holding, Baidu Inc, Novartis AG during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Tweedy, Browne International Value Fund II - Currency Unhedged.

Novan to Participate in the Virtual Investor Roundtable Event
12 Nov, 2021 Yahoo! Finance

– Live moderated video webcast discussion among management and Pediatric Dermatology Thought Leader on Wednesday, November 17th at 1:00 PM ET – DURHAM, N.C., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, joined by a pediatric dermatology thought leader, will participate in the Virtual Investor Roundtable Event on Wednesday, November 17, 2021 at 1:00 PM ET.As part

Looking Into Novan's Return On Capital Employed
11 Nov, 2021 FinancialContent

According to Benzinga Pro data, during Q3, Novan (NASDAQ:NOVN) posted sales of $737.00 thousand. Earnings were up 8.11%, but Novan ...

NOVN: KINSOLUS: A Solution for Molluscum
11 Nov, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT Third Quarter 2021 Results On November 10, 2021, Novan Inc. (NASDAQ:NOVN) reported third quarter financial results in a press release concurrent with the filing of Form 10-Q . A conference call and webcast was also held to update investors on financial and operational results. Most recently, the FDA conditionally accepted

Novan Provides Corporate Update and Reports Third Quarter 2021 Financial Results
10 Nov, 2021 Yahoo! Finance

– Company executing on plans for three potential New Drug Application (NDA) filings in three years with the first submission targeted in Q3 2022 for lead program SB206 in molluscum contagiosum – – Advancing priority development pipeline assets by progressing SB019, for the treatment of SARS-CoV-2, toward a Phase 1 study in 2022, and SB204, for the treatment of acne vulgaris, toward a registrational Phase 3 study in 2023 – – Company to host update conference call and webcast today at 8:30 a.m. ET

Novan Announces Favorable Preclinical Safety Data and Intent to Advance SB019 for Treatment of COVID-19
09 Nov, 2021 Yahoo! Finance

– Data indicate that intranasal administration of SB019 formulation containing berdazimer sodium is well-tolerated and safe under the conditions of preclinical study – – Company believes the promising conclusions from this Good Laboratory Practices (GLP) study support advancement of the SB019 program toward in-human clinical development – – Pre-IND (Investigational New Drug) application activities are underway with a target of an IND submission no later than Q2 2022 – DURHAM, N.C., Nov. 09, 2021

JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th
04 Nov, 2021 FinancialContent
Novan Announces Fireside Chat Hosted by Jonathan Aschoff, Ph.D. of ROTH Capital Partners
04 Nov, 2021 Yahoo! Finance

– Company highlights rationale of strategic pathway towards potential commercialization in collaboration with commercial solutions provider, Syneos Health – – Discusses recent progress and expected next steps toward NDA submission, on track and targeting Q3 2022 – – Video webcast of in-person fireside chat now available – DURHAM, N.C., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive

Novan to Report Third Quarter 2021 Financial Results on November 10, 2021
03 Nov, 2021 Yahoo! Finance

Company to host conference call and webcast on Wednesday, November 10, 2021, at 8:30 a.m. ETDURHAM, N.C., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its third quarter 2021 financial results on Wednesday, November 10th. Novan management will host a conference call and live audio webcast to discuss the operational and financial results at 8:30 a.m. ET that same day. The call will be led by Paula Brown Stafford, Presi

Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum
02 Nov, 2021 Yahoo! Finance

– Mr. Johnson brings broad commercial expertise with over 30 years of leadership spanning dermatology marketing, sales, sales management, digital marketing and managed care –– Company received conditional acceptance from U.S. FDA for use of KINSOLUS™ as brand name for SB206, if approved – – First New Drug Application (NDA) remains on target with submission expected in Q3 2022 – DURHAM, N.C., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
26 Oct, 2021 FinancialContent

Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
19 Oct, 2021 FinancialContent

Gainers Sesen Bio (NASDAQ:SESN) stock moved upwards by 17.82% to $1.19 during Tuesday's after-market session. This security traded ...

How Good Are Novan's Earnings? | Return On Capital Employed
01 Oct, 2021 FinancialContent

According to Benzinga Pro data, during Q2, Novan (NASDAQ:NOVN) posted sales of $747.00 thousand. Earnings were up 14.85%, but Novan ...

NOVN: B-SIMPLE4 Safety Data
27 Sep, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT B-SIMPLE4 Safety Data In follow up to the June release of topline results for B-SIMPLE4 and additional detail provided in an update on September 9 th , Novan (NASDAQ:NOVN) reported safety data from its pivotal B-SIMPLE4 on September 23 rd . The results were in line with previous trials and SB206 was well tolerated. Treatment

A Few names on TOP of my watchlist for the coming week
26 Sep, 2021 FinancialContent
Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206
23 Sep, 2021 FinancialContent
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
20 Sep, 2021 FinancialContent

– Live fireside chat with Paula Brown Stafford, President and Chief Executive Officer of Novan on Tuesday, September 28 at 8:00 AM ET –

NOVN: Syneos Selected as Commercialization Partner
20 Sep, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT September Update On September 9, 2021, Novan (NASDAQ:NOVN) hosted a corporate update conference call and webcast. The call was led by Novan President and CEO, Paula Brown Stafford, who reviewed recent milestones and plans over the next several years. Ms. Stafford detailed Novan’s revenue prospects in the US which are

12 Health Care Stocks Moving In Wednesday's After-Market Session
15 Sep, 2021 FinancialContent

Gainers Larimar Therapeutics (NASDAQ:LRMR) shares rose 10.53% to $13.75 during Wednesday's after-market session. The ...

12 Health Care Stocks Moving In Thursday's Intraday Session
09 Sep, 2021 FinancialContent

Gainers Impel NeuroPharma (NASDAQ:IMPL) shares increased by 22.16% to $20.29 during Thursday's regular session. ...

Novan Announces Strategic Priorities and Outlines Key Milestones
09 Sep, 2021 FinancialContent
Novan Engages Syneos Health as Commercial Solutions Provider for SB206
08 Sep, 2021 FinancialContent
Novan to Present at H.C. Wainwright 23rd Annual Global Investment Conference
07 Sep, 2021 FinancialContent

Novan, Inc (NOVN) is a NASDAQ Common Stock listed in , ,

970x250